NVIDIA has introduced the BioNeMo toolkit, which is intended to support life sciences AI agents. The toolkit is being used by companies such as Certara to accelerate drug discovery, and it is also being integrated into lab analytics platforms by Tecan. The introduction of the BioNeMo toolkit appears to be part of a broader trend of AI being applied to scientific workflows and research and development in the pharmaceutical industry.